I-Mab Morphs Into U.S.-Only Company, Sells China Assets For

I-Mab Morphs Into U.S.-Only Company, Sells China Assets For $80M

I-Mab Morphs Into U.S.-Only Company, Sells China Assets For $80M

seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

Oregon , United States , San Diego , California , China , Suzhou , Jiangsu , Japan , Germany , Wuhan , Hubei , Taian , Shandong , Guangzhou , Guangdong , Australia , India , Hangzhou , Zhejiang , Ireland , Taiwan , Shanghai , Maryland , Rockville , Taipei , T Ai Pei , North Carolina , German , Australian , Mycovia Pharma , Jiangsu Hengrui Pharma , Innovent Biologics , Taiwan National Research Program For Biopharmaceuticals , Guangzhou Fermion Technology , National Development Fund , Research Center , Shenzhen China Medical System Holdings , Translational Center , China Development Industrial Bank , I Mab Biopharma , I Mab Hangzhou , Greater China , National Research Program , Taian Venture Capital , National Development , China Medical System Holdings , Winhealth Investment , Vifor Fresenius Medical Care Renal , German Life Science , Continuous Glucose Monitoring , Trinity Biotech , Joint Partnership , Hengrui Pharma , China Phase , New Drug Application , Regene Therapeutics , Fermion Technology , Drug Studio ,